alexa Study of Metabolic Syndrome in Chronic Obstructive Pulmonary Disease and its Clinical Implications | OMICS International| Abstract
ISSN: 2161-105X

Journal of Pulmonary & Respiratory Medicine
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Pulm Respir Med,
  • DOI: 10.4172/2161-105X.1000490

Study of Metabolic Syndrome in Chronic Obstructive Pulmonary Disease and its Clinical Implications

Panda G1, Patro M1, Seth HK1, Pattanaik M1, Meher BK1* and Sahoo J2
1Department of Pulmonary Medicine, Sriram Chandra Bhanja Medical College and Hospital, Mangalabag, Cuttack, Odisha, India
2Department of Cardiology, Sriram Chandra Bhanja Medical College and Hospital, Mangalabag, Cuttack, Odisha, India
*Corresponding Author : Meher BK, Department of Pulmonary Medicine, Sriram Chandra Bhanja Medical College and Hospital, Mangalabag, Cuttack, Odisha, India, Tel: 7978218832, Email: [email protected]

Received Date: Apr 05, 2019 / Accepted Date: Apr 15, 2019 / Published Date: Apr 22, 2019

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is not only a disease of lungs but is also associated with significant extra-pulmonary effects. Metabolic syndrome (MS) and associated cardiovascular morbidity and mortality are more frequent in COPD.
Objective: To study the prevalence of MS in hospitalised COPD patients. To compare their clinical characteristics with presence of MS. To correlate the presence of MS with GOLD spirometric severity and ABCD groups.
Methods: With a cross-sectional design, 100 hospitalised COPD patients were studied. They were asked about history, subjected to clinical examination and investigations to screen for MS and comorbidities. MS was identified using modified NCEP-ATPIII criteria and COPD was diagnosed based on GOLD guidelines 2017. They were classified based on spirometric grading and combined ABCD assessment. Being hospitalised patients, all subjects were either in group B or group D.
Results: MS was found in 40% of COPD patients. Patients with coexisting MS had more number of exacerbations (mean 2.50 vs. 2.03), prior history of hospitalisation (37.5% vs. 30%), longer duration of hospitalisation (7.25 vs. 4.73 days) and higher prevalence of comorbidities like diabetes and hypertension, as compared to those with COPD alone. The prevalence of MS decreased with increasing spirometric severity, with highest prevalence in mild obstruction (66.7%). Prevalence of MS was higher in group D patients as compared to group B (48.4% vs. 25%).
Conclusion: The presence of MS is frequent in hospitalised COPD patients and is associated with adverse clinical parameters. It is more common in earlier spirometric grades and Group D patients. Hence, this population should be considered for screening for MS.

Keywords: COPD; GOLD; Metabolic syndrome

Citation: Panda G, Patro M, Seth HK, Pattanaik M, Meher BK, et al. (2019) Study of Metabolic Syndrome in Chronic Obstructive Pulmonary Disease and its Clinical Implications. J Pulm Respir Med 9: 490. Doi: 10.4172/2161-105X.1000490

Copyright: © 2019 Panda G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top